ENVALITH
神戸天然物化学株式会社 logo

KNC Laboratories Co., Ltd.

6568Growth MarketServices

神戸天然物化学株式会社 logo
KNC Laboratories Co., Ltd.6568
Reference Indicators

Market Cap

98¥100M

P/E (Forecast)

16.2x

P/B

0.7x

Dividend Yield (Forecast)

2.62%

ROE

5.6%

EV/EBITDA

5.0x
Financial Summary
Unit: ¥M
Item
2022Mar 2022
2023Mar 2023
2024Mar 2024
2025Mar 2025
2026Mar 2026
Net Sales
7,4408,6289,1548,1789,093
Cost of Sales
5,3335,3245,8585,8586,705
Gross Profit
2,1073,3033,2952,3202,388
SG&A Expenses
1,0121,1401,2141,5481,363
Operating Income
1,0942,1632,0817711,024
Non-operating Income
20452317739
Non-operating Expenses
11991934
Ordinary Income
1,1022,1992,0949291,028
Extraordinary Income
04140
Extraordinary Losses
18631252
Pre-tax Income
9162,1722,0939271,025
Income Taxes
273629600190259
Net Income
6431,5421,493737766
EBITDA
2,0233,0823,0031,6512,257
Gross Margin
28.3%38.3%36.0%28.4%26.3%
Operating Margin
14.7%25.1%22.7%9.4%11.3%
ROA
4.6%10.0%8.0%3.7%3.5%
ROE
6.2%13.8%12.0%5.5%5.6%